— Know what they know.
Not Investment Advice

ENTX NASDAQ

Entera Bio Ltd.
1W: +4.0% 1M: -2.0% 3M: +67.2% YTD: +61.6% 1Y: +54.6% 3Y: +297.8% 5Y: -40.5%
$2.86
-0.03 (-1.04%)
 
Weekly Expected Move ±6.8%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 37 · $141.0M mcap · 40M float · 4.74% daily turnover · Short 38% of daily vol

Balance Sheet Trends

Total Assets
$16M +70.3% ▲
5Y CAGR: +10.5%
Total Liabilities
$3M +120.8% ▲
5Y CAGR: +5.5%
Shareholders Equity
$13M +62.1% ▲
5Y CAGR: +11.8%
Cash & Investments
$7M -17.9% ▼
5Y CAGR: -3.7%
Total Debt
$490K +80.1% ▲
5Y CAGR: +2.6%
Net Debt
-$7M +21.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$25M$12M$11M$9M$7M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$25M$12M$11M$9M$7M
Net Receivables$183K$246K$0$126K$219K
Inventory$0$0$0$0$0
Other Current Assets$254K$294K$238K$186K-$219K
Total Current Assets$25M$13M$11M$9M$7M
Property, Plant & Equip.$395K$229K$488K$332K$134K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$80K$90K
Other Non-Current Assets$46K$6K$6K$6K-$90K
Total Non-Current Assets$658K$278K$508K$418K$134K
Total Assets$26M$13M$12M$9M$16M
— Liabilities —
Accounts Payable$166K$17K$83K$132K$448K
Short-Term Debt$0$0$0$0$230K
Deferred Revenue$15K$0$0$0$0
Other Current Liabilities$455K$300K$500K$339K$2M
Total Current Liabilities$3M$1M$1M$1M$2M
Long-Term Debt$0$0$0$0$260K
Other Non-Current Liab.$138K$32K$32K$32K$429K
Total Non-Current Liabilities$261K$32K$288K$134K$689K
Total Liabilities$3M$1M$1M$1M$3M
— Equity —
Common Stock$0$0$1K$1K$1K
Retained Earnings-$82M-$95M-$104M-$114M-$125M
Accumulated OCI$41K$41K$41K$41K$41K
Total Stockholders Equity$23M$12M$10M$8M$13M
Total Liabilities & Equity$26M$13M$12M$9M$16M
— Key Metrics —
Total Debt$302K$91K$390K$272K$490K
Net Debt-$25M-$12M-$11M-$8M-$7M
Total Investments$0$0$0$80K$90K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms